|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-2-5
|
|
pubmed:abstractText |
The presence of antiphospholipid antibodies (aPL) has been associated with vascular occlusive events. However, the role of aPL in predicting ischemic events, particularly recurrent ischemic stroke, is controversial.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1538-3598
|
|
pubmed:author |
pubmed-author:APASS Investigators,
pubmed-author:BreyRobin LRL,
pubmed-author:CostiganTeresa MTM,
pubmed-author:LevinBruceB,
pubmed-author:LevineSteven RSR,
pubmed-author:LuYimengY,
pubmed-author:MohrJ PJP,
pubmed-author:MurphyAA,
pubmed-author:RhineCandiC,
pubmed-author:SaccoRalph LRL,
pubmed-author:SciaccaRobert RRR,
pubmed-author:ThompsonJ L PJL,
pubmed-author:TilleyBarbara CBC,
pubmed-author:TriplettDouglas ADA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
291
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
576-84
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14762036-Aged,
pubmed-meshheading:14762036-Antibodies, Antiphospholipid,
pubmed-meshheading:14762036-Anticoagulants,
pubmed-meshheading:14762036-Aspirin,
pubmed-meshheading:14762036-Cohort Studies,
pubmed-meshheading:14762036-Female,
pubmed-meshheading:14762036-Humans,
pubmed-meshheading:14762036-Male,
pubmed-meshheading:14762036-Middle Aged,
pubmed-meshheading:14762036-Platelet Aggregation Inhibitors,
pubmed-meshheading:14762036-Proportional Hazards Models,
pubmed-meshheading:14762036-Prospective Studies,
pubmed-meshheading:14762036-Randomized Controlled Trials as Topic,
pubmed-meshheading:14762036-Stroke,
pubmed-meshheading:14762036-Survival Analysis,
pubmed-meshheading:14762036-Thrombosis,
pubmed-meshheading:14762036-Warfarin
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
|
|
pubmed:affiliation |
Department of Neurology, Mt Sinai School of Medicine, New York, NY 10029-6574, USA. steven.levine@mssm.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
